loading animation for AJAX calls
Items per page:   25 | 50 | 75 | 100

195 Reports in Biotechnology

Proteomics: Technologies and Global Markets

Published - Oct 2018 | Analyst - Bhavna Joshi| Code - BIO034E

The global market for proteomics should grow from $7.9 billion in 2017 to $16.8 billion by 2022 at a compound annual growth rate (CAGR) of 16.2% for the period of 2017-2022.

Protein Analysis: Subfocus on Oncoproteomics

Published - Oct 2018 | Analyst - Anuj Pathak| Code - BIO168A

The global market for protein analysis should grow from $11.6 billion in 2018 to $19.0 billion by 2023 at a compound annual growth rate (CAGR) of 10.4% from 2018 through 2023.

Genetic Modification Therapies Clinical Applications: Gene Thera...

Published - Sep 2018 | Analyst - John Bergin| Code - BIO159A

The global market for genetic modification therapies should grow from $2.3 billion in 2018 to reach $17.4 billion by 2023, growing at a compound annual growth rate (CAGR) of 49.9% during the forecast period of 2018-2023.

Biomarkers: Technologies and Global Markets

Published - Sep 2018 | Analyst - BCC Research Staff| Code - BIO061E

The global market for biomarkers should grow from $78.9 billion in 2018 to $136.5 billion by 2023 at a compound annual growth rate (CAGR) of 11.6% from 2018 through 2023.

Next Generation Sequencing for Non-invasive Prenatal Testing: Glo...

Published - Sep 2018 | Analyst - BCC Research Staff| Code - BIO173A

The global market for non-invasive prenatal testing (NIPT) should grow from $1.9 billion in 2018 to reach $3.1 billion by 2023, growing at a compound annual growth rate (CAGR) of 10.2% during the forecast period of 2018-2023.

Global Markets for Enzymes in Industrial Applications

Published - Sep 2018 | Analyst - BCC Research Staff| Code - BIO030K

The global industrial enzymes market should reach $7.0 billion by 2023 from $5.5 billion in 2018 at a compound annual growth rate (CAGR) of 4.9% for the period 2018-2023.

Switching to CRISPR–Cas Systems from Uncultivated Microbes

Published - Sep 2018 | Analyst - Mike (Ke Ke) Fan| Code - BIO172A

CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) technology is currently the biggest discovery in life science. As a precise gene editing tool, it has been widely used in many areas with a great potential to treat human diseases. While some CRISPR-based therapeutic studies are moving to clinical trials, CRISPR's therapeutic promise was brought into question when some issues were found that could become major obstacles in moving the great genome editing tools to the clinic.While many groups are actively resolving these obstacles, the significant challenges to minimize the immunological risks and avoid potential tumorgenicity have received more attention as big concerns for CRISPR-Cas therapeutics advancing toward the clinic. We believe it is timely to summarize and analyze the emerging immunological risk and potential tumorgenicity with the CRISPR-Cas systems, to predict how this exciting genome editing market will affect other related segments of the entire life science market in the next few years. We also hope our opinion could serve as a "crowd crystal" on those discussions in response to the issues, and bring a better market environment for the technology to be sharpened and advanced into clinical applications.

Current Research & Developments Status of Chimeric Antigen Recept...

Published - Aug 2018 | Analyst - Paul Taylor| Code - BIO162A

The global market for Chimeric Antigen Receptor (CAR) T-cell therapies will grow from nearly $467.0 million in 2018 to $2.9 billion by 2023 at a compound annual growth rate (CAGR) of 44.1% for the period of 2018-2023.

Adoptive Transfer of Autologous Lymphocytes Targeting Somatically...

Published - Aug 2018 | Analyst - Paul Taylor| Code - BIO171A

Adoptive Cell Therapies (ACTs) and the infusion of autologous or redirected tumor-specific T-cells have the potential to drastically impact the treatment of a variety of cancers, especially common epithelial cancers. This report summarizes the current state of clinical research and trials, explains the impact of ACTs on the treatment of several metastasized malignancies, and also raises important concerns about the scalability and compatibility of TILs.

Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnosti...

Published - Aug 2018 | Analyst - Todd Graham| Code - BIO157A

The global market for polymerase chain reaction (PCR) in point of care (POC) diagnostics totaled $2.9 billion in 2018 and is estimated to reach $4.8 billion by 2023, growing at a compound annual growth rate (CAGR) of 10.6% for the period of 2018-2023.

Microbial Products: Technologies, Applications and Global Markets

Published - Aug 2018 | Analyst - Andrew McWilliams| Code - BIO086D

The global microbes and microbial products market should reach $302.4 billion by 2023 from $186.3 billion in 2018 at a compound annual growth rate (CAGR) of 10.2% for the period 2018-2023.

Immunohistochemistry (IHC): Global Markets to 2022

Published - Aug 2018 | Analyst - Vijay Laxmi| Code - BIO161A

The global immunohistochemistry market totaled $1.6 billion in 2017 and is estimated to reach $2.3 billion by 2022, growing at a compound annual growth rate (CAGR) of 7.8% for the period of 2017-2022.

Global Markets for Media, Sera and Reagents in Biotechnology

Published - Aug 2018 | Analyst - BCC Research Staff| Code - BIO014K

The global market for media, sera and reagents in biotechnology should reach $5.5 billion by 2023 from $4.1 billion in 2018 at a compound annual growth rate (CAGR) of 6.0% for the period 2018-2023.

Synthetic Biology: Global Markets

Published - Jul 2018 | Analyst - John Bergin| Code - BIO066E

The global market for synthetic biology will grow from nearly $4.4 billion in 2017 to $13.9 billion by 2022, with a compound annual growth rate (CAGR) of 26.0% for the period of 2017-2022.

Cardiac Biomarkers: Technologies and Global Markets

Published - Jul 2018 | Analyst - Paul Taylor| Code - BIO128C

The global market for cardiac biomarker will grow from $6.3 billion in 2017 to $9.9 billion by 2022, at a compound annual growth rate (CAGR) of 9.5% for the period of 2017-2022

Digital Polymerase Chain Reaction (PCR) Technology: Global Market...

Published - Jun 2018 | Analyst - Todd Graham| Code - BIO137B

The global digital polymerase chain reaction (PCR) technology market totaled $425.0 million in 2017 and is estimated to reach $746.0 million by 2022, growing at a compound annual growth rate (CAGR) of 11.9% for the period of 2017-2022.

Exosome Diagnostics and Therapeutics: Global Markets

Published - Jun 2018 | Analyst - Marianna Tcherpakov| Code - BIO149B

The global market for exosome industry should reach $180.0 million by 2023 from $25 million in 2018 at a compound annual growth rate (CAGR) of 48.4% for the period 2018-2023.

The Chinese Market for DNA Sequencing

Published - Jun 2018 | Analyst - Jason Chen| Code - BIO152B

The Chinese market for DNA sequencing totaled $1.2 billion in 2017. The market should total $2.9 billion by 2022, growing at a compound annual growth rate (CAGR) of 19.0% during 2017-2022.

Biosimilars: Global Markets

Published - Apr 2018 | Analyst - Kamna Jhamb| Code - BIO090C

The global biosimilars market reached nearly $5.5 billion in 2017 and is expected to reach $20.8 billion by 2022, with a compound annual growth rate (CAGR) of 30.5% from 2017 through 2022.

Artificial Blood: Global Markets to 2027

Published - Apr 2018 | Analyst - BCC Research Staff| Code - BIO164A

The global market for potential artificial blood is estimated to grow from nearly $6.2 billion in 2022 to $15.6 billion by 2027 with a compound annual growth rate (CAGR) of 20.5% for the period of 2022-2027.

Cell Therapy Processing: Global Markets and Technologies

Published - Apr 2018 | Analyst - Sangeeta Rai| Code - BIO160A

The global market for cell therapy reached $1.3 billion in 2017 and should reach $5.0 billion in 2022 at a compound annual growth rate (CAGR) of 30.9% for the period of 2017-2022.

The Global Market for Stem Cells

Published - Apr 2018 | Analyst - Paul Evers| Code - BIO035G

The global market for stem cells totaled $7.4 billion in 2017 and is estimated to reach $14.8 billion by 2022, growing at a compound annual growth rate (CAGR) of 14.7% for the period of 2017-2022.

Biologics Development and Manufacturing Testing: Technologies and...

Published - Mar 2018 | Analyst - David Peters| Code - BIO155A

The global biological safety testing market should reach $13.1 billion by 2022 from $5.1 billion in 2017 at a compound annual growth rate (CAGR) of 20.9%, from 2017 to 2022.

Mobile Apps for DNA Sequencing: Global Markets

Published - Mar 2018 | Analyst - Smruti Munshi| Code - BIO156A

The global market for mobile applications for DNA sequencing reached $28.8 billion in 2017. The market should reach $248.3 billion by 2022, at a compound annual growth rate (CAGR) of 53.8% during 2017-2022.

Drug Discovery Technologies

Published - Feb 2018 | Analyst - Shalini Shahani Dewan| Code - BIO020F

The global market for drug discovery technologies totaled $54.7 billion in 2017. The market should reach $85.8 billion by 2022, growing at a compound annual growth rate (CAGR) of 9.4% during 2017-2022.

19 Upcoming Reports in Biotechnology

Chromatography in Pharmaceuticals and Biotechnology: Global Markets

Target Date - Oct 2018| Author - Kamna Jhamb| Code - BIO163A| Price - $5,500

Report Includes

  • An overview of the global market for chromatography in pharmaceuticals and biotechnology
  • Analyses of global market trends with data from 2017, estimates for 2018, and projections of compound annual growth rates (CAGRs) through 2023
  • Identification of the segments that should experience high growth during the time frame covered
  • Information on competitor initiatives, and information pertaining to research and development status of chromatography in pharmaceuticals and biotechnology
  • Comprehensive profiles of major players in the industry

Notify Me

High Content Screening/Imaging: Technologies and Global Markets

Target Date - Oct 2018| Author - Anuj Pathak| Code - BIO166A| Price - $5,500

Report Includes

  • An overview of the global markets for high content screening/imaging technologies
  • Analyses of global market trends, with data from 2016, 2017, and projections of compound annual growth rates (CAGRs) through 2022
  • Coverage of various microscope and imaging technologies in the industry
  • Detailed analysis of the technological advancement in cytometers, light sources, detectors/sensors and liquid handling instruments
  • Discussion of the various market motivators i.e. increasing R&D budget, advantages over manual and HTS, technological advancement, and automation
  • Company profiles of major players in the industry, including Albany Molecular Research Inc. (AMRI), Cell Signaling Technology, Essen Instruments, NemaMetrix Inc. and TTP LabTech

Notify Me

Bioinformatics: Technologies and Global Markets

Target Date - Oct 2018| Author - Vijay Laxmi| Code - BIO051D| Price - $5,500

Report Includes

  • An overview of the global market for bioinformatic technologies and their applications.
  • Analyses of global market trends, with data from 2014 through 2017, and projections of compound annual growth rates (CAGRs) through 2022.
  • Discussion of the goal of bioinformatics and their role in systems biology.
  • Insight into the application of bioinformatics on drug development, including cheminformatics, next-generation sequencing, metagenomics and data management systems.
  • Detailed analyses of the influential factors, such as R&D spending in the pharmaceutical sector, the growth of agrobiotechnology, and the expanded use of microbial genomics.
  • Detailed profiles of major companies in the market, including Genologics Lifesciences Software Inc., Smartgene Services SARL, Dassault Systemes SA, Astrid Bioscience GMBH, Conexio Genomics Private Ltd. And 3rd Millennium Inc.

Notify Me

Cell-based Assays: Technologies and Global Markets

Target Date - Oct 2018| Author - Sathya Durga| Code - BIO080D| Price - $5,500

Report Includes

  • Detailed overview of the global market for cell-based arrays
  • Analyses of global market trends with data from 2017, estimates for 2018, and projections of compound annual growth rates (CAGRs) through 2023
  • Technological assessment of the cell-based assays available and currently used and their markets; the competitive environment; the market for cell assays in newly emerging regions; and the impact of instrumentation and robotics on the market
  • Information about significant products and assays; issues and trends; the current market status of cell-based assays; and major issues involved in the research and development (R&D) of more effective cell-based approaches for drug discovery
  • A set of important assays, technologies and the latest developments and market share by assay type and company, with a special emphasis on the U.S. market
  • Statistical information on the types of cancers prevalent worldwide
  • Key market players and their comprehensive corporate profiles

Notify Me

 
Get Notified when New Reports are published
MEMBERSHIP

 

CUSTOM